Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (71)

SortShow
Name Institution Why
Petr Jarolim, Ph.D., M.D.Brigham and Women's Hospital Why?
Neal I. Lindeman, M.D.Brigham and Women's Hospital Why?
Philip J Saylor, M.D.Massachusetts General Hospital Why?
Matthew Steven Davids, M.D.Dana-Farber Cancer Institute Why?
Daniel J. DeAngelo, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Stephen Earl Sallan, M.D.Dana-Farber Cancer Institute Why?
Naomi Julia Serling-Boyd, M.D.Massachusetts General Hospital Why?
Sanjeeva P. Kalva, M.D., M.B.,B.S.Massachusetts General Hospital Why?
Edward W. Boyer, M.D., Ph.D.Brigham and Women's Hospital Why?
Akihiro Nakajima, M.D.Massachusetts General Hospital Why?
Richard M. Stone, M.D.Dana-Farber Cancer Institute Why?
Jennifer Williams Mack, M.D.Dana-Farber Cancer Institute Why?
Traci Ann Wolbrink, M.D.Boston Children's Hospital Why?
John Edmund Mayer Jr., M.D.Boston Children's Hospital Why?
Jennifer Leigh Crombie, M.D.Dana-Farber Cancer Institute Why?
Per Page    Page  of 5last Nextnext
Prev
Search Criteria
  • Tumor Lysis Syndrome
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.